Switch
Homepage
facebook
IG
Other Hospital
CMUH App
Department Introduction
Clinical Trial Center | Excellence
:::
Excellence
- The center's contract review of clinical trials acquired accreditation from the Joint Commission International (JCI) and the Association for the Accreditation of Human Research Protection (AAHRPP). Its relevant subject protection measures were highly rated as being perfect by AAHRPP members.
- Center chief Professor Chung-yi Hsu serves as the Taiwanese ambassador for the Society for Clinical Research Sites (SCRS). In addition to the annual SCRS Taiwan conference held in Taiwan, the center is tasked with providing the latest SCRS courses and information to the major hospitals and clinical trial centers in Taiwan, which have not yet joined the society.
- In 2016, the center was allowed to join the International Clinical Trials Center Network (ICN). The organization was set up by the clinical trials center under the University of Zurich in Switzerland, Harvard University in the US, the University of Cambridge in the UK, the University of Hong Kong, and other world-class universities. The members are required to have considerable expertise in carrying out clinical trials. Members of the organization meet together for exchanges on a regular basis every year. On top of sharing recent developments in countries, it has also contributed to the exchange of staff among members and the joint implementation of clinical trials initiated by transnational researchers.
- Professor Hsu serves as the PI of the center-led Stroke Consortium, which is one of the 12 national disease consortiums. The Stroke Consortium is based on the whole Taiwan apoplexy registration database and the stroke center network, with a total of 60 hospitals admitted worldwide. The consortium not only has big real word database for a reliable big data basis for stroke research in Taiwan, but also has introduced several multinational multi-center clinical trial protocols to be performed in Taiwan. Moreover, the center serves as the command center, coordinating the closure of the protocols in Taiwan hospitals. The results of the clinical trial ATACH-II launched by the National Institutes of Health (NIH), the US and carried out by Taiwan's major clinical trials centers led by the center were published in New England Journal of Medicine renowned for its high citation rates, with Center chief Professor Hsu listed as the first co-author in the Asia region, and the hospital named as the Regional Coordinating Center in the appendix to the paper.
Facebook
IG
YouTube
▲